valuation time, page-9

Nice close today @ $0.053 well above the days $0.512 VWAP churn on such significant volume. It's been nice to see the rise in price restrained & using volume with the move. No triple figure percentage rises or even high double digits for that matter just steady rises on volume. Still trading at ridiculous values based on everything from peer comparisons not just in monetary value but how SM6 has been proving itself through the cohorts continual updates - it looks in many instances equal to or better than other therapies hence why Orphan registration has likely been granted by FDA & EMA over the last few weeks - being open label it has provided much greater visibility. Progress from what is known looks as good if not better than existing drugs or those in other trials + it works favourably in combination either way.

The recent developments along with the completion of Phase II in coming days or weeks significantly opens the window. Look at deals in the target area both size & scope - this company wont be like it is for long & I think we are about to see the transformation.

Without question the FDA's move yesterday coupled with the Phase II completion has significantly changed the whole game & company position in regards to the pharmaceutical & biotechnology companies that have been showing significant interest throughout this trial.

Interesting week coming next.